Document Detail

Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
MedLine Citation:
PMID:  576229     Owner:  NLM     Status:  MEDLINE    
A patient is described with a galactorrhea-amenorrhea syndrome and an enlargement of the sella turcica. Pregnancy occurred after induction of ovulation with bromocriptine (and 2.5 years after pituitary irradiation). Periodic assessment of the visual fields showed an increase in size of the blind spots after 10 weeks and a moderate bitemporal hemianopsia after 22 weeks, which improved spontaneously after 30 weeks of pregnancy. One month after delivery the visual field of the left eye was almost normalized, while that of the right eye showed a definite improvement. Prior radiotherapy need not prevent visual complications from enlargement of pituitary adenomas during pregnancy.
S W Lamberts; H J Seldenrath; H G Kwa; J C Birkenhäger
Related Documents :
9880429 - Adrenal tumors and pregnancy.
19350859 - Diagnostic and therapeutic dilemmas of hypercortisolemia during pregnancy: a case report.
7959909 - Role of adrenal in establishment and development of conceptus in unilaterally ovariecto...
2974679 - Foetal adrenal steroids--initiation of human parturition.
10692849 - Control of parturition in ruminants.
2226319 - Effect of bilateral splanchnic nerve section on adrenal function in the ovine fetus.
19016619 - The construction and prospects of the chongqing twin children database.
9363199 - Differential effects of plasma from normal and ectopic gestation on lymphocyte prolifer...
22263609 - Lopinavir/ritonavir trough concentrations with the tablet formulation in hiv-1-infected...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  44     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1977 Jan 
Date Detail:
Created Date:  1977-03-21     Completed Date:  1977-03-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  180-4     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amenorrhea / blood,  drug therapy*
Bromocriptine / adverse effects*,  therapeutic use
Ergolines / adverse effects*
Estradiol / blood
Follicle Stimulating Hormone / blood
Galactorrhea / blood*,  drug therapy*
Hemianopsia / chemically induced*
Lactation Disorders / blood*,  drug therapy*
Luteinizing Hormone / blood
Pituitary Neoplasms / complications
Pregnancy Complications
Prolactin / blood
Visual Fields
Reg. No./Substance:
0/Ergolines; 25614-03-3/Bromocriptine; 50-28-2/Estradiol; 9002-62-4/Prolactin; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transient recurrence of hyperthyroidism after delivery in Graves' disease.
Next Document:  Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum.